Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 8.3B | 6.8B | 6.9B | 7.6B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 5.6B | 5.4B | 5.0B | 5.5B |
Operating income | 2.5B | 1.4B | 1.8B | 1.9B |
Non operating interest income | ||||
Income | 13M | 20M | 18M | 19M |
Expense | 157M | 139M | 165M | 139M |
Other income expense | — | — | — | — |
Pretax income | 4.2B | 1.4B | 3.1B | 480M |
Tax provision | 490M | 477M | 346M | 347M |
Net income | 3.7B | 882M | 2.8B | 134M |
Basic EPS | 12.7 | 0.9 | 8.7 | -1.5 |
Diluted EPS | 12.7 | 0.9 | 8.7 | -1.5 |
Basic average shares | 247.9M | 247.1M | 248.0M | 248.4M |
Diluted average shares | 247.9M | 247.1M | 248.0M | 248.4M |
EBITDA | 4.7B | 1.9B | 3.6B | 972M |
Net income from continuing op. | 4.2B | 1.4B | 3.1B | 480M |
Minority interests | -539M | -672M | -614M | -513M |
Preferred stock dividends | 0 | 0 | 0 | 0 |